The 2022 edition of ICD-10-CM Z87.19 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
alcohol abuse and dependence ( F10.-) Lipid infiltration and fatty degeneration of liver parenchymal cells due to alcohol abuse; may be associated with alcohol hepatitis or cirrhosis. Lipid infiltration of the hepatic parenchymal cells that is due to alcohol abuse. The fatty changes in the alcoholic fatty liver may be reversible, ...
The 2022 edition of ICD-10-CM K70.0 became effective on October 1, 2021.
Lipid infiltration of the hepatic parenchymal cells that is due to alcohol abuse. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of triglycerides accumulated. 443 Disorders of liver except malignancy, cirrhosis or alcoholic hepatitis without cc/mcc.
The 2022 edition of ICD-10-CM Z85.05 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
Z87.19 is a billable diagnosis code used to specify a medical diagnosis of personal history of other diseases of the digestive system. The code Z87.19 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code Z87.19 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Z87.19 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
Z86.39 is a billable diagnosis code used to specify a medical diagnosis of personal history of other endocrine, nutritional and metabolic disease. The code Z86.39 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code Z86.39 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
A metabolic disorder occurs when abnormal chemical reactions in your body disrupt this process. When this happens, you might have too much of some substances or too little of other ones that you need to stay healthy. There are different groups of disorders.
Z86.39 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
ICD Code Z87.1 is a non-billable code. To code a diagnosis of this type, you must use one of the two child codes of Z87.1 that describes the diagnosis 'personal history of diseases of the digestive system' in more detail.
Use a child code to capture more detail. ICD Code Z87.1 is a non-billable code.